Two key questions underly the problem of microcirculatory thrombosis: What triggers its occurrence in small blood vessels and at what point does it become irreversible, leading to organ damage and tissue necrosis. Since the most frequent underlying condition for microcirculatory thrombosis is endotoxin-producing gram-negative bacteremia, a cause of an estimated 18,000 deaths per year in the US, we plan to continue our studies in two ways. One is based on a search for endotoxin binding sites (receptors) on the cells involved in microcirculatory thrombosis. The second way is based on regulating cellular function to prevent endotoxin- induced changes, including Lipid A-mediated activation of protein kinase C in human platelets and other cells. The role of interleukin I in mediating Lipid A-induced vascular changes will be evaluated. To this end the development and application of inhibitors modifying cellular responses to endotoxin offers a novel approach to endotoxic shock and microvascular thrombosis. Another major goal of our studies is further characterization of clumping factor on staphylococci, the most primitive organisms known to have a fibrinogen receptor. We plan to locate the binding domain for human fibrinogen gamma chain carboxy terminal receptor recognition site and establish the molecular mechanism of formation of fibrinogen-staphylococcal clumping linkages. We plan to develop a functional model of the clumping receptor-fibrinogen interaction as a prototype for a similar type of interaction of human fibrinogen with eukaryotic receptors. Thus, our research should expand the knowledge of (1) microcirculatory thrombosis triggered by endotoxin, in particular the interaction of Lipid A with the membrane of human platelets and human endothelial cells; (2) the molecular mechanism whch determines when microvascular thrombosis is reversible and when it becomes irreversible, as related to refractoriness of vascular cells to physiological regulatory mechanisms. The practical results of these fundamental approaches will be the development of a new class of inhibitors that would be useful for blocking the effects of endotoxin and staphylococci in microcirculatory thrombosis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
4R37HL030647-10
Application #
3485989
Study Section
Special Emphasis Panel (NSS)
Project Start
1983-01-01
Project End
1997-03-31
Budget Start
1992-04-10
Budget End
1993-03-31
Support Year
10
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Hawiger, J; Veach, R A; Liu, X Y et al. (1999) IkappaB kinase complex is an intracellular target for endotoxic lipopolysaccharide in human monocytic cells. Blood 94:1711-6
Torgerson, T R; Colosia, A D; Donahue, J P et al. (1998) Regulation of NF-kappa B, AP-1, NFAT, and STAT1 nuclear import in T lymphocytes by noninvasive delivery of peptide carrying the nuclear localization sequence of NF-kappa B p50. J Immunol 161:6084-92
Zhang, L; Torgerson, T R; Liu, X Y et al. (1998) Preparation of functionally active cell-permeable peptides by single-step ligation of two peptide modules. Proc Natl Acad Sci U S A 95:9184-9
Hawiger, J (1997) Cellular import of functional peptides to block intracellular signaling. Curr Opin Immunol 9:189-94
Liu, K Y; Timmons, S; Lin, Y Z et al. (1996) Identification of a functionally important sequence in the cytoplasmic tail of integrin beta 3 by using cell-permeable peptide analogs. Proc Natl Acad Sci U S A 93:11819-24
Lin, Y Z; Yao, S Y; Hawiger, J (1996) Role of the nuclear localization sequence in fibroblast growth factor-1-stimulated mitogenic pathways. J Biol Chem 271:5305-8
Hawiger, J (1995) Mechanisms involved in platelet vessel wall interaction. Thromb Haemost 74:369-72
Donald, R; Ballard, D W; Hawiger, J (1995) Proteolytic processing of NF-kappa B/I kappa B in human monocytes. ATP-dependent induction by pro-inflammatory mediators. J Biol Chem 270:9-12
Donahue, J P; Patel, H; Anderson, W F et al. (1994) Three-dimensional structure of the platelet integrin recognition segment of the fibrinogen gamma chain obtained by carrier protein-driven crystallization. Proc Natl Acad Sci U S A 91:12178-82
Cordle, S R; Donald, R; Read, M A et al. (1993) Lipopolysaccharide induces phosphorylation of MAD3 and activation of c-Rel and related NF-kappa B proteins in human monocytic THP-1 cells. J Biol Chem 268:11803-10

Showing the most recent 10 out of 21 publications